$CERU moving in an orderly fashion above the upper

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
114
$CERU moving in an orderly
fashion above the upper bollie.
$3.08

Website
logo-cerulean.png


10-Q
11/3/16
1642481658_otc.jpeg

Ultra low float
Shares Outstanding 27.44M
Float 18.03M

% Held by Insiders 33.41%
% Held by Institutions 47.20%
Shares Short 3 1.52M
Short Ratio 0.44
Short % of Float 11.60%
Shares Short (prior month) 924.47k




No particular news except Seeking Alpha
has been following it publicly on positive moves.


Premarket Gainers as of 9:10 am
SA News•Today, 9:20 AM•1 Comment
After Hours Gainers / Losers
SA News•Yesterday, 5:35 PM•1 Comment
Midday Gainers / Losers
SA News•Yesterday, 12:43 PM
Healthcare- Top 5 Gainers / Losers as of 12:15 PM
SA News•Yesterday, 12:15 PM
Cerulean up 44% in early trading
SA News•Yesterday, 10:46 AM•12 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Yesterday, 9:15 AM
Premarket Gainers / Losers as of 9:10 am
SA News•Tue, Mar. 14
Midday Gainers / Losers
SA News•Mon, Mar. 13•13 Comments
Healthcare - Top 5 Gainers / Losers as of 12:10 PM
SA News•Mon, Mar. 13•2 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Mar. 13•3 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Thu, Feb. 9•2 Comments
Healthcare - Top 5 Gainers / Losers as of 11:00 am
SA News•Tue, Feb. 7•8 Comments
Premarket Gainers / Losers as of 9:10 am
SA News•Mon, Feb. 6•4 Comments
Cerulean Pharma receives deficiency notice from Nasdaq
SA News•Nov. 18, 2016•6 Comments
Cerulean Pharma Inc. SEC Filing - Current report (8-K) November 18, 2016
SEC Filings•Nov. 18, 2016

Other News

3 Reasons Why Cerulean Pharma (CERU) is a Great Momentum Stock
at Zacks.com (Jan 9, 2017)
Cerulean Announces Promotion Of Scott Eliasof, PhD To Senior Vice President And Chief Scientific Officer
at TheStreet (Oct 26, 2016)
First Week of June 2017 Options Trading For Cerulean Pharma (CERU)
at TheStreet (Oct 25, 2016)
Mid-Day Market Update: Crude Oil Up 2.75%; Cerulean Pharma Shares Surge On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Stock Shoots Higher On News Of Novartis Collaboration
at Benzinga (Oct 19, 2016)
Cerulean Announces Technology Platform Collaboration
at TheStreet (Oct 19, 2016)
Cerulean Announces Data Presentations At The 2016 European Society For Medical Oncology Annual Meeting
at TheStreet (Oct 6, 2016)
Barclays Remains Positive On Cerulean Pharma Despite Failed Renal Cancer Trial
at Benzinga (Aug 30, 2016)
Cerulean Announces Reduction In Force
at TheStreet (Aug 18, 2016)
Cerulean Pharma (CERU) Stock Tumbles on Lead Kidney Cancer Drug Failure
at TheStreet (Aug 18, 2016)

< >


Cerulean Pharma Inc., a clinical-stage company, develops nanotechnology-based therapeutics in the areas of oncology and other diseases in the United States. The company’s lead product candidate is CRLX101, a tumor targeted nanoparticle-drug conjugate (NDC), which is in Phase 2 clinical development in patients with renal cell carcinoma; and in Phase 2 and Phase 1b clinical development in patients with ovarian cancer. It is also developing CRLX301, a platform-generated NDC clinical candidate, which is in Phase 1/2a clinical trials. The company has a strategic collaboration with Novartis to develop nanoparticle-drug conjugates for various cancer tumor targets. The company was formerly known as Tempo Pharmaceuticals, Inc. and changed its name to Cerulean Pharma Inc. in October 2008. Cerulean Pharma Inc. was incorporated in 2005 and is based in Waltham, Massachusetts.

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Microsoft Faces Legal Scrutiny Over Alleged AI Pricing Issues

Updated Category News Views 331

Microsoft's Pricing Controversy in Australia Recently, Microsoft's corporate integrity has come under fire due to allegations from Australia's competition watchdog. The Australian Competition and Consumer Commission (ACCC) has brought legal action against the tech giant, claiming that it misled around 2.7 million customers regarding the pricing structures of its Microsoft...

Continue Reading
Strategic Changes in Automotive Dealership Management and Growth

Updated Category News Views 266

Performance Brokerage Services Facilitates Dealership Transition Performance Brokerage Services is proud to announce its role in the successful sale of Covina Hills Chevrolet, marking a significant step in dealership operations. The transaction involved the transfer of ownership from Jim Ross to Braeden Mueller, showcasing the dedicated efforts of the team at Performance...

Continue Reading
SI-BONE Reports Strong Revenue Growth and Financial Outlook

Updated Category News Views 132

Financial Highlights for SI-BONE in 2024 SI-BONE, Inc. (NASDAQ: SIBN), renowned for its advancements in medical technology for sacropelvic disorders, has recently shared preliminary financial results that reflect its commitment to innovation and growth. With an impressive estimated revenue between $48.8 to $49.0 million for the fourth quarter of 2024, this signals a...

Continue Reading
Air India's Bold Move: 85 New Airbus Jets and Future Plans

Updated Category News Views 378

Air India's Strategic Expansion with Airbus Air India is making striking moves to rejuvenate its operations by securing an exciting new order for 85 Airbus aircraft. This decision aligns with the company's vision for a significant turnaround, especially considering its historic order of 470 jets made just a year ago. As sources reveal, this latest acquisition could serve...

Continue Reading
The Alpine High Saga: Deceptive Practices and Consequences

Updated Category News Views 691

Apache and the Alpine High Controversy In 2016, Apache Corporation, known as APA Corporation (NASDAQ: APA), made headlines with an announcement that sent ripples through the investment community. They declared a significant oil and gas discovery in the Alpine High region of Texas, promising tremendous returns to excited investors. This announcement sparked interest, yet...

Continue Reading